We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
-13.01%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$276M
AUM Growth
-$52.8M
Cap. Flow
+$7.73M
Cap. Flow %
2.8%
Top 10 Hldgs %
72.28%
Holding
60
New
12
Increased
22
Reduced
11
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 74.36%
2 Communication Services 9.92%
3 Consumer Discretionary 5.83%
4 Financials 4.76%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$62.8M 22.76%
848,709
+31,825
+4% +$2.65M
REGN icon
2
Regeneron Pharmaceuticals
REGN
$72.9B
$24.2M 8.77%
52,080
+3,461
+7% +$1.86M
CXRX
3
DELISTED
Concordia International Corp. Common Stock
CXRX
$23.7M 8.59%
557,500
NFLX icon
4
Netflix
NFLX
$301B
$22.5M 8.13%
2,174,840
+1,933,340
+801% +$20.8M
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$15.3M 5.56%
773,899
+7,175
+0.9% +$227K
BX icon
6
Blackstone
BX
$107B
$13.1M 4.76%
422,470
+3,949
+0.9% +$143K
AGN
7
DELISTED
Allergan plc
AGN
$11.5M 4.15%
42,189
+425
+1% +$131K
INSY
8
DELISTED
Insys Therapeutics, Inc.
INSY
$11.1M 4%
388,346
+3,702
+1% +$136K
AVDL
9
DELISTED
Avadel Pharmaceuticals
AVDL
$9.29M 3.37%
569,819
+5,294
+0.9% +$117K
BWLD
10
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$6.03M 2.18%
31,180
-13,000
-29% -$2.44M
ASRT
11
DELISTED
Assertio
ASRT
$5.94M 2.15%
+5,254
New +$8.97M
PRGO icon
12
Perrigo
PRGO
$1.43B
$5.69M 2.06%
36,186
+336
+0.9% +$61.6K
JNP
13
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$5.67M 2.05%
481,459
-16,562
-3% -$183K
ALXN
14
DELISTED
Alexion Pharmaceuticals
ALXN
$5.23M 1.89%
33,424
+314
+0.9% +$57.3K
META icon
15
Meta Platforms (Facebook)
META
$1.51T
$4.92M 1.78%
54,776
+33,241
+154% +$3.05M
KYTH
16
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$4.34M 1.57%
57,925
JAZZ icon
17
Jazz Pharmaceuticals
JAZZ
$16.1B
$4.32M 1.57%
32,559
-687
-2% -$118K
AMZN icon
18
Amazon
AMZN
$2.48T
$4.27M 1.55%
166,780
+101,840
+157% +$2.57M
QLTI
19
DELISTED
QLT Inc
QLTI
$4.24M 1.53%
1,592,993
BSTC
20
DELISTED
BioSpecifics Technologies Corp.
BSTC
$3.2M 1.16%
73,586
+12,029
+20% +$649K
LGND icon
21
Ligand Pharmaceuticals
LGND
$5.94B
$3.1M 1.12%
57,987
+539
+0.9% +$32.7K
TARO
22
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$2.9M 1.05%
20,312
-29,738
-59% -$4.16M
IPXL
23
DELISTED
Impax Laboratories, Inc.
IPXL
$2.23M 0.81%
63,373
+5,550
+10% +$250K
SBUX icon
24
Starbucks
SBUX
$118B
$1.86M 0.67%
32,690
+20,130
+160% +$1.13M
CMG icon
25
Chipotle Mexican Grill
CMG
$43B
$1.76M 0.64%
122,350
-98,450
-45% -$1.4M

Similar funds

JW Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, JW Asset Management held 60 positions worth $276M, down 16% from $329M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

JW Asset Management's Q3 2015 filing shows 12 new, 22 increased, 11 reduced and 4 closed positions. Its largest new stake was Assertio: 5,254 shares worth $5.94M. The largest sale was Apple, an estimated $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 77% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • JW Asset Management's largest Q3 2015 buy was Assertio: 5,254 shares worth $5.94M.
  • JW Asset Management added most to Netflix in Q3 2015, an estimated $20.8M increase.
  • JW Asset Management's biggest Q3 2015 reduction was Taro Pharmaceutical Industries Ltd., cutting an estimated $4.16M.
  • JW Asset Management fully exited Apple in Q3 2015, selling an estimated $24.7M.
  • JW Asset Management's ten largest holdings make up 72% of its $276M portfolio in Q3 2015.
  • JW Asset Management opened 12 new positions and closed 4 in Q3 2015.
  • JW Asset Management's portfolio value fell 16% quarter-over-quarter to $276M.

Based on JW Asset Management's 13F filing for Q3 2015, filed 12 Nov 2015.